Hamzepour Shokoufeh MD is categorized under Internal Medicine Doctors in Miami, FL and active since 2010.
Hamzepour Shokoufeh MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Shokoufeh Hamzepour at the company’s single location by writing to 1611 Nw 12th Avenue, Miami, Florida FL 33136 or by phoning (305) 585-6408. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Hamzepour Shokoufeh MD |
Contact Person: | Shokoufeh Hamzepour |
Address: | 1611 Nw 12th Avenue, Miami, Florida 33136 |
Phone Number: | (305) 585-6408 |
Website Address: | dermatology.med.miami.edu |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Hamzepour Shokoufeh MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Shokoufeh Hamzepour for inquiries that concern Hamzepour Shokoufeh MD by calling the company number (305) 585-6408, as your correspondence is most welcome. Additionally, the physical location of the single location of Hamzepour Shokoufeh MD can be found at the coordinates 25.790538,-80.214982 as well as the street address 1611 Nw 12th Avenue in Miami, Florida 33136.
For its online presence, you may visit Hamzepour Shokoufeh MD’s website at dermatology.med.miami.edu and engage with its social media outlets through on Twitter and on Facebook.